ABSTRACT
INTRODUCTION
analyses on 117 TETs, leading to define four subtypes defined by genomic hallmarks
64
[17]; GTF2I was confirmed as an oncogene associated with type A thymoma, and Akt using "phospho-Akt (Ser 476) antibody" (Cell signaling, 9271S), mTOR using
136
"mTOR PrecisionAb TM Antibody" (BIORAD, VPA00174), phospho mTOR using
137
"phospho-mTOR (Ser2448) Antibody" (Cell signaling, 2971), phospho p70S6k using
138
"phospho-p70 S6 Kinase (Thr389) Antibody" (Cell signaling, 9205) and -actin
139
(Monoclonal Anti-β-Actin−Peroxidase antibody, Sigma) as recommended.
140
Immunoreactive bands were detected with goat anti-rabbit IgG (whole molecule) -
141
peroxidase antibodies produced in goat (Sigma) and revealed using the "Clarity Max™
142
Western ECL Blotting Substrate" (BIORAD) on a "ChemiDoc™ Imaging System" (Table 2) . 
163
The potential impact of discovered mutation was analyzed with the "PolyPhen-2
164
(Polymorphism Phenotyping v2) predictive model".
165

Statistical analysis
166
Statistical analyses (threshold of  = 0.05) were performed using the t test with the 167 "GraphPad Prism" (GraphPad) software. All tests were done with a significant 168 threshold of  = 0.05.
169
RESULTS
170
Clinical features
171
From January 2015 to December 2017, thirteen patients (9 males and 4 females, mean phase microscope showed that cells had an epithelioid morphology (Fig 1) . Cells (Fig 2A) . The mutation 213 induced a K  Q amino-acid change, predicted as deleterious with the PolyPhen-2 214 prediction. We also detected a GTF2I mutation for tumor 3154, reported as a (Fig 2B) . The mutation located on exon 15 was associated with a non-conservative T/A 217 transversion leading to L H amino-acid change in the deduced amino-acid sequence
218
( Fig 2B) . 
#3154
Activation of the Akt/ mTOR/ P70S6K pathway in thymomas 225 The Akt/ mTOR pathway is a key pathway implicated in cell proliferation. We analyzed 226 its activation in thymomas as well as in normal thymuses from cardiac surgery. In these 227 latter ones, only Akt and the activated phospho-Akt were expressed while mTOR,
228
phospho mTOR or phospho P70S6K proteins were undetectable (Fig 3A) . In 229 thymomas, both Akt and mTOR were activated (Fig 3A) , as shown by the detection of except in 3146-B2 thymoma (Fig 4) . This suggests that the activation of the Akt/ mTOR 258 pathway might participate to the cell proliferation associated with tumor growth. 
Effects of rapamycin treatment on tumoral TECs proliferation
266
We analyzed the effect of rapamycin, an inhibitor of mTOR, on cell proliferation of 267 thymic epithelial cells. We focused our analysis on three cell cultures, at early 268 passages, derived from AB (# 3147), B2 (# 3146) and B2/ B3 (#3149) thymomas 269 because they had good proliferative abilities with ~24 hours doubling time (not shown)
270
that is a prerequisite for studying rapamycin inhibition over a 72-hour period.
271
Importantly, these three thymomas and their derived cells expressed mTOR and phospho-mTOR (Figures 3 and 4) . The proliferation rate was measured daily, in that they were significantly reduced after 48 hours with rapamycin (Fig 6) . Deciphering the molecular events in thymomas has remained a major challenge given 
